Skip to content
OpenCapital
Get started

QuidelOrtho Corporation QDEL EBITDA

EBITDA at other companies

Opko Health logo
Opko HealthOPK
-$28.82M+34.0%
Abbott logo
AbbottABT
——
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
——
Danaher logo
DanaherDHR
——
Revvity logo
RevvityRVTY
——
Quest Diagnostics logo
Quest DiagnosticsDGX
——

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%—

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Calculated from QuidelOrtho Corporation’s reported figures.

−$31.8Mebit+
$112.9MDepreciation Depletion & Amortization
=$81.1M

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's EBITDA?
QuidelOrtho Corporation (QDEL) reported EBITDA of $81.1M in Q1 2026.
How has QuidelOrtho Corporation's EBITDA changed year-over-year?
QuidelOrtho Corporation's EBITDA decreased by 41.9% year-over-year, from $139.7M to $81.1M.
What is the long-term trend for QuidelOrtho Corporation's EBITDA?
Over 4 years (2021 to 2025), QuidelOrtho Corporation's EBITDA has grown at a -16.0% compound annual growth rate (CAGR), from $958.7M to -$477.2M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.